Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Hum Immunol. 2008 Nov;69(11):811-4. doi: 10.1016/j.humimm.2008.08.276. Epub 2008 Sep 24.

CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer.

Author information

  • Center for Cell and Gene Therapy, Departments of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA. Rongfuw@bcm.tmc.edu <Rongfuw@bcm.tmc.edu>

Abstract

Regulatory T (Treg) cells induce immune tolerance by suppressing host immune responses against self- or nonself-antigens, thus playing critical roles in the prevention of autoimmune diseases, but they may inhibit antitumor immunity and promote tumor growth. Increasing evidence demonstrates that elevated proportions of CD4(+) Treg cells are present in various types of cancers and suppress antitumor immunity. However, less is known about CD8(+) Treg cells and their detrimental effects on immunotherapy directed toward cancer. Toll-like receptor (TLR)-8 signaling may directly regulate the suppressive function of CD4(+) and CD8(+) Treg cells. Linking TLR signaling to the functional control of Treg cells opens the potential for intriguing opportunities to manipulate TLR signaling to control the suppressive function of different subsets of Treg cells for effective immunotherapy of cancer.

PMID:
18817828
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk